pro-inflammatory cytokines and growth factors such as interleukin-1β (IL-1β), tumor necrosis factor (TNF), and nerve growth factor-β (NGF-β) have had limited success in OA, however, because of the modest disease-modifying effects and unanticipated side effects. 10 Currently, the role of inflammation does not fully explain the complex pathophysiology of OA. A better understanding of disease pathology and progression to PTOA is needed to identify new targets for intervention.
Previous work has characterized cytokines, 3 matrix metalloproteinases (MMPs), 3 and lipid metabolites 23 elevated in ankle synovial fluid in the acute phase following intra-articular fracture. Lipid metabolites were also evaluated in a subset of patients 6 months postsurgery, but the acute elevation of many metabolites after injury had resolved by this time point. 23 These previous results were collected retrospectively using a patient-matched control data set, in which synovial fluid was collected from both the injured and contralateral ankles, and suggest that acutely elevated inflammatory mediators may activate metabolic pathways that then drive progression to PTOA.
Prior studies describing the joint environment as OA develops also suggest that changes in amino acid metabolism are associated with OA progression in the knee. 25 Ratios of branched-chain amino acids (leucine, isoleucine, and valine) have been previously identified as potential serum biomarkers of knee OA. 45 Specifically, serum valine to histidine and xleucine (defined as the combination of leucine and isoleucine) to histidine ratios showed significant elevation in patients with knee OA both in a clinical study and an independent replication cohort. The levels of serum valine and xleucine increased in OA patients, whereas histidine was similar in the OA and control populations. 45 Subsequent research demonstrated that the correlation between individual metabolites in blood plasma and knee SF in patients with OA is modest, suggesting that systemic differences may not be an appropriate proxy for local metabolic changes in the joint. 46 In addition, a study by Zhang and coworkers demonstrated that OA is metabolically heterogeneous, supporting the use of a combination of biomarkers to identify patients at risk for end-stage disease. 12, 28, 47 The goal of this study was to characterize the biochemical signature of amino acids, peptides, and amino acid metabolites in ankle synovial fluid following intra-articular fracture to identify additional biomarkers that may prove to be associated with progression to PTOA.
Methods

Patient Enrollment and Study Design
This study was a retrospective cohort study. All procedures and patient enrollment were completed after obtaining Institutional Review Board approval and informed consent.
Nineteen patients with a unilateral intra-articular ankle fracture were enrolled in the study (Table 1) , with a mean age of 42 (range = 20-63). Intra-articular fracture was defined as any fracture of the fibula or tibia in which the fracture line extended to the cartilage surface of the ankle joint as seen on plain radiographs. All patients had a pain-free contralateral ankle joint with no radiographic evidence of arthritis, which served as a matched control. Patients were excluded if they had prior history of ankle trauma, diabetes, hemophilia, a systemic inflammatory disease such as rheumatoid arthritis (RA), or injury not requiring operative intervention. All enrolled patients underwent open reduction and internal fixation of their ankle fractures. Seven patients participated in a second bilateral synovial fluid collection during a operative procedure for syndesmotic screw removal for additional symptomatic relief after 6 months. Although these ankle fractures represent a range of severity, previous work was unable to detect discrete differences between fracture types with or without concurrent soft tissue injury. 23 
Ankle Joint Lavage and SF Aspiration
Synovial fluid was obtained from both the injured and contralateral ankles at the time of surgery (mean = 17 days following fracture; range = 8 to 40 days) and again at 6 months postsurgery, following methods described previously. 23 Briefly, after lower extremity operative scrub and draping, lavage and arthrocentesis were performed on each ankle joint using an 18-gauge needle and 10-mL syringe filled with 7 mL of sterile saline. The needle was inserted using the anteromedial approach under fluoroscopic guidance, and the same 7 mL of fluid was used to lavage the ankle joint 3 times prior to sample collection for standardization and to ensure near-complete collection of all joint synovial fluid. Aspirated synovial fluid was transferred to 15-mL conical tubes (Falcon, Thermo Fisher Scientific, Waltham, MA) and centrifuged at room temperature (3500 RPM, 15 minutes). Supernatant was collected and stored at −80°C. No adverse events or complications were reported.
Serum Collection
Whole blood samples were also obtained to quantify serum urea concentrations. 23 Collected blood was allowed to sit for 20 minutes in glass tubes and centrifuged at room temperature (3500 RPM, 15 minutes). The serum fraction was aspirated, aliquoted, and stored at −80°C in cryopreservation tubes (Nalgene, Thermo Fisher Scientific).
Quantification of Dilution Factors
Synovial fluid and serum urea concentrations were determined using a colorimetric assay (QuantiChrom Urea Assay Kit, BioAssay Systems, Hayward, CA) and used to quantify individual sample dilution factors. 23 The dilution factor was calculated by dividing the serum urea concentration by the synovial fluid urea concentration for each individual ankle, as the ratio of urea in synovial fluid relative to serum is constant. 22 Synovial fluid concentrations were corrected by this factor to allow for accurate comparisons across patients, as the volume of fluid aspirated during collection procedures varied across patients.
Metabolite Analysis
Synovial fluid samples were submitted for global metabolic profiling (Metabolon, Inc, Durham, NC) and analyzed following methods described previously. 23 Briefly, UPLC-MS/ MS optimized for basic species, UPLC-MS/MS optimized for acidic species, and GC-MS were used for detection of small molecules. Metabolites were identified via comparison to a chemical reference library and use of Metabolon software. Quality control was ensured with internal standards, pooled technical replicates, and water blanks throughout the experimental process. Instrument and process variability procedures were also performed as previously noted. 23 
Data Manipulation
Metabolite concentrations were normalized by the calculated dilution factor 23 and the data set was then scaled to set the median of each metabolite equal to 1. Metabolites with concentrations lower than the limit of detection were assigned the minimum value observed for that metabolite.
Statistics
All data were log-transformed for statistical analysis. Random forest (RF) classification was performed using the entire data set. 23 Briefly, this technique uses an unbiased classification system to generate a decision tree based on a randomly selected subset of the data and then passes the remaining data down the decision tree to obtain a class prediction for each sample. 6, 17 This process is repeated thousands of times and used to generate a forest that can then be used to assign a predictive class to each of the samples. Class predictions are then compared to true sample classes (injured or healthy at baseline or 6 months postsurgery) to determine the accuracy of the method. A predictive accuracy of 50% is expected by random chance when comparing 2 groups. This process was used to produce an importance rank order of metabolites to identify those that contributed the most to differentiating between groups. Fold-changes in synovial fluid metabolite concentration (injured/contralateral) were calculated for each patient and used for statistical comparisons. Metabolites in the synovial fluid of injured and contralateral ankles at baseline were compared using a matched pairs t test (α < 0.05). Metabolites in the synovial fluid of injured ankles in a subset of patients at baseline and 6 months were compared using repeated measures analysis of variance with posttest contrasts (α < 0.05). The concentration of a metabolite was considered "altered" if the change was significant (α < 0.05) and if the metabolite fold-change value was greater than 2.1. Branched-chain amino acid (BCAA) ratios were individually calculated for each patient, and a 2-tailed t-test comparing the array of values for the healthy and injured ankles were compared (α < 0.05).
Metabolite Correlation Analysis
Correlations were evaluated between the metabolites elevated in the injured ankle synovial fluid at baseline and (1) MMPs, (2) patient age, and (3) time from fracture. MMP concentrations in synovial fluid were taken from a previous study. 3 Two correlations with patient age were performed: one evaluating the contralateral ankles alone and a second including both the injured and contralateral ankles. Briefly, the CORREL function in Microsoft Excel was used to generate the Pearson correlation coefficient (r) and a 2-tailed analysis was used with n = 19 and α < 0.01, defining the significance criterion as r > 0.575. 23 
Results
Patient characteristics and synovial fluid dilution factors at time of fracture and 6 months are listed in Table 1 . Global metabolic profiling of synovial fluid samples yielded detectable concentrations of 243 identifiable metabolites, 66 of which were categorized as amino acids, peptides, and amino acid metabolites.
Statistical comparisons between injured and contralateral control ankles revealed 19 amino acids, peptides, and amino acid metabolites that were significantly elevated following ankle fracture (P < .05, Table 2 ). The mean fold-change in concentration in the injured ankle synovial fluid relative to that of the control, calculated across the 19 patient samples, was no less than 2.1 for each of these identified metabolites. Two peptides, DSGEGDFXAEGGGVR* and HWESASXX*, exhibited the largest fold-increases, with values of 43.7 and 19.8, respectively ( Table 2) . Eight of the 17 elevated amino acids and amino acid metabolites in injured ankles were involved with the tryptophan and BCAA metabolism pathways, and included C-glycosyltryptophan, 3-indoxyl sulfate, tryptophan, kynurenine, indolepropionate, 4-methyl-2-oxopentanoate, 3-methyl-2-oxovalerate, and 3-methyl-2-oxobutyrate. Glutathione metabolites, oxidized glutathione (GSSG) and cysteine-glutathione disulfide, exhibited the most elevated fold-change values of 15.6 and 9.72, respectively (Table 2 ). Representative elevations in metabolite concentration corresponding to each of these metabolic pathways for fractured ankles at baseline compared to contralateral control ankles are shown in Figure 1 . None of the 66 amino acids, peptides, or amino acid metabolites in the injured ankle synovial fluid had concentrations that significantly differed from those in the control ankle 6 months post-surgery.
We also sought to determine whether BCAA ratios 45 could be used as a predictor of OA progression in ankle synovial fluid. Histidine was shown to be significantly elevated in fractured ankles at baseline (Table 2 ), but there was no significant increase in valine, leucine, or isoleucine. There was no significant difference between the ratios of any BCAA to histidine for the fractured or control ankles (P > .05).
RF classification was used previously 23 to identify the metabolites that are most likely to differentiate between the injured and contralateral control groups. RF analysis showed a predictive accuracy of 84% for injured versus contralateral control ankles at baseline and identified 3 amino acid metabolites within the top 30 distinguishing metabolites. Cysteine-glutathione disulfide and glutamate were listed within the top 14 distinguishing metabolites. Spermidine was also included in the top 30 differentiating metabolites but was not significantly elevated in the injured ankle at baseline (P > .05). RF comparison of injured versus contralateral control ankles 6 months post-surgery showed a predictive accuracy of 64%.
The most significant correlations between amino acids, peptides, and amino acid metabolites and MMPs were between DSGEGDFXAEGGGVR* and cysteine-glutathione disulfide and MMP9, and histidine and 3-indoxyl sulfate and MMP1, all of which had correlation coefficients greater than 0.8 ( Figure 2 ). Of the 16 significant correlations (r > 0.575) between metabolites and MMPs, 12 were with either MMP1 or MMP9. The remaining 4 significant correlations involved either MMP2 or MMP10; there were no significant correlations between amino acids, peptides, or amino acid metabolites and MMP3. No significant correlations were identified between patient age and any of the metabolites in the contralateral or injured ankles (r < 0.575). In addition, there was no evidence of a correlation of metabolites with time from fracture within the window used for patients in the current study (mean = 17 days following fracture; range = 8 to 40 days).
Discussion
The goal of this study was to look for significant changes in amino acid metabolism within the ankle joint following traumatic injury, which may contribute to a biochemical signature associated with progression to PTOA. Synovial fluid samples from both the injured and contralateral control ankles of 19 patients with intra-articular fracture were analyzed using global metabolic profiling, and a 6-month followup was performed in 7 of these patients. Results indicated a significant, acute elevation of many amino acids, peptides, and amino acid metabolites associated with endstage arthritis, 25, 27, 31, 43 raising the question of an association between these products and PTOA.
The metabolites with the largest fold-increases in concentration following fracture were the DSGEGDFXAEGGGVR* and HWESASXX* peptides, which are degradation products of fibrinogen and the C3f fragment of the C3 complement protein, respectively. 13, 14 High concentrations of fibrinogen and fibrin breakdown products have been found in inflammatory synovial fluid, such as that taken from the knees of patients with RA, and leukocyte proteases including elastase may be responsible for fibrinogen proteolysis. 9, 18 The healing response to joint injury includes the elevated local production of cytokines, proteases, and damage-associated molecular patterns (DAMPs), all of which contribute to catabolic and pro-inflammatory signaling and recruitment of immune cells. 20, 26, 36 The local inflammatory response and recruitment of leukocytes 20 may therefore contribute to the elevated concentration of the DSGEGDFXAEGGGVR* peptide in ankle synovial fluid following intra-articular fracture. The complement cascade is also involved in the healing response, as it plays an important role in the removal of pathogens and damaged cells. 26 The overactivation of complement pathways has been implicated in a number of diseases, including RA, and various complement components including C3 are significantly elevated in patients with OA. 38, 42 The role of inflammation and innate immunity in both the acute healing process as well as in OA implicate a possible contribution of these processes to post-traumatic arthritis.
Glutathione metabolites also showed significant elevation after ankle fracture, with high mean-fold increases in GSSG and cysteine-glutathione disulfide. Cysteineglutathione disulfide also contributed to differentiation between the injured ankle and contralateral control SF at baseline in the RF analysis. The presence of high levels of reactive oxygen species (ROS) released due to tissue injury can damage cells, and glutathione is an intracellular antioxidant that mitigates the effects of ROS. 8 Increased levels of GSSG and cysteine-glutathione disulfide are both indicators of oxidative stress, a proposed contributor to the development of OA and chondrocyte senescence. 4, 27, 34 Chondrocytes produce ROS in response to pro-inflammatory cytokines including IL-1, TNF-α, fibroblast growth factor (FGF), and tissue growth factor-β (TGF-β). 27 The inflammatory response induced by an intra-articular ankle fracture thus seems to create an environment of oxidative stress within the joint, which may damage the joint tissue and contribute to development of PTOA. Multiple metabolites involved with the tryptophan pathway (C-glycosyltryptophan, 3-indoxyl sulfate, tryptophan, kynurenine, indolepropionate) were also significantly elevated following ankle fracture. Tryptophan breakdown into kynurenine depends on the enzyme indoleamine 2,3-dioxygenase, or IDO. Proinflammatory cytokines such as interferon-γ (IFN-γ) induce IDO-mediated breakdown of tryptophan in response to inflammation. 1, 37, 41 Reduced levels of tryptophan and elevated levels of kynurenine have also been reported in the blood of patients with RA, due to enhanced IDO activity in synoviocytes. 37 The significant elevations of both tryptophan and kynurenine concentrations in ankle SF following injury found in this study suggest that multiple mechanisms are likely involved with tryptophan metabolism.
Amino acids glutamate and aspartate also showed significant elevation in the ankle synovial fluid following intraarticular fracture. Glutamate and aspartate are involved with adenosine triphosphate (ATP) production and are known to affect cell metabolism and signaling, anti-oxidative functions, and immunity. 25 Levels of these amino acids were elevated in synovial fluid from patients with synovitis and have been associated with inflammatory mediators in synovial fluid of patients with OA. 25, 31, 43 These metabolites were also increased in the knee joints of rats following anterior cruciate ligament transection, and the authors concluded that glutamate and aspartate are likely involved with progression toward PTOA. 19 Glutamate has been shown to enhance inflammation by stimulating synoviocyte production of TNF-α in primary cultures derived from knee synovial fluid. 30 Changes in glutamate receptor N-methyl-D-aspartate (NDMA) expression may also contribute to OA progression through its role in inflammation, immune responses, pain, cytokine and MMP regulation, and chrondrocyte and synoviocyte proliferation. 43 The important role of these amino acids in various inflammatory processes, as well as elevated levels in patients with OA, suggests that persistent changes following acute injury may lead to end-stage disease.
None of the 19 amino acids, peptides, or amino acid metabolites that showed significant elevation in the injured ankle at baseline varied drastically from the contralateral control ankle 6 months post-surgery. As there is no standard method for sample size calculations of metabolic profiling studies, 5 it is possible that the small sample size of 7 patients at this time point limited the statistical power of the data. However, although no significant differences were detected at 6 months post-surgery, a number of these metabolites did show mean fold-changes greater than 2.1, including GSSG, cysteine-glutathione disulfide, C-glycosyltryptophan, glutamate, DSGEGDFXAEGGGVR*, and HWESASXX*. These results indicate that some of the previously described changes in glutathione, tryptophan, and glutamate metabolism may be chronic and contribute to longterm pathology.
The concentrations of many amino acids and amino acid metabolites correlate with age, 21 so it was important to evaluate the role of age in our results. Previous studies have shown that serum concentrations of histidine, aspartate, glutamate, ornithine, and C-glycosyltryptophan are associated with age. 21, 32 A study by Kouchiwa and coworkers evaluated amino acid metabolites and showed that serum concentrations of histidine decrease with age and aspartate concentration increases with age in males only, but that concentrations of glutamate and ornithine increase with age in both males and females. 21 Despite these results, we did not observe significant correlations between the elevated metabolites and age in the ankle synovial fluid of any group. Gender differences in amino acid metabolites were not evaluated in the current study because of the limited sample size.
However, many significant correlations were shown between various amino acid and peptide metabolites and MMPs. Previous work demonstrated that MMP1, MMP2, MMP3, MMP9, and MMP10 were all significantly elevated in the ankle synovial fluid following intra-articular ankle fracture, and that MMP1, MMP2, and MMP3 were still significantly elevated in the synovial fluid from the injured ankle 6 months postsurgery. 2, 3 The strongest correlations between metabolites and MMPs were with MMP1 and MMP9, although additional significant correlations involved MMP2 and MMP10. The strongest correlations in our previous work identifying lipid biomarkers in the ankle synovial fluid following intra-articular fracture were also with MMP1 and MMP9. 23 The 4 amino acids, peptides, and amino acid metabolites with the strongest correlations were all significantly elevated at baseline, and both cysteine-glutathione disulfide and DSGEGDFXAEGGGVR* were still elevated at 6 months. Cysteine-glutathione disulfide was, additionally, listed within the top 30 metabolites most likely to differentiate between the injured and contralateral control groups by the RF analysis. The strong correlation between these elevated metabolites and MMPs enhance the likelihood that these correlations may be used to predict progression to PTOA. MMPs are involved in extracellular matrix degradation with various targets including collagen (MMP1, MMP2, and MMP9) and non-collagen (MMP3, MMP10) proteins. 7 Pro-inflammatory cytokines including IL-1β and TNF-α induce expression of MMP1, MMP3, and MMP9, whereas MMP2 is constitutively expressed. 7 Kynurenine has also been shown to increase expression of both MMP1 and MMP3 in dermal fibroblasts, so it is possible that the increased concentration of kynurenine in the SF upregulates MMP1 by the same mechanism. 24 Chondrocytes are more metabolically active in OA and produce proteinases in response to inflammatory stimuli, such as those produced during the acute phase of healing after joint trauma. 7 Thus, as cartilage is broken down after injury, the breakdown products induce an inflammatory response, increasing the presence of cytokines that then upregulate proteinases. These pathways form a positive feedback loop that continues to degrade the joint tissue. 7 MMP1 in particular is an important mediator of collagen degradation and joint destruction. 7 Irreparable collagen degradation contributes to the loss of articular cartilage, a hallmark of OA, and increased collagenase activity has been documented in advanced disease. 15, 33, 39 Upregulated activity of another collagenase, MMP8, and MMP3 was also demonstrated in damaged articular cartilage from human ankle joints. 11 The correlations between amino acids, peptides, and amino acid metabolites with MMPs further confirm the role of inflammation in the observed changes in metabolism.
In conclusion, the results presented here illustrate the presence of altered amino acid metabolism within the synovial fluid of fractured ankles, raising the question of whether some of these contribute to the development of PTOA following traumatic ankle injury. Nineteen of the 66 amino acids, peptides, and amino acid metabolites were elevated in the synovial fluid of injured ankles at time of fracture compared to that of the contralateral control ankles. These identified metabolites complement our previous work characterizing the cytokine, MMP, and lipid profiles of ankle synovial fluid after intra-articular fracture. Defining the pathophysiology of this disease will likely allow for the creation of a biochemical signature for patients at greater risk of developing PTOA, as well as early intervention via local delivery of a therapy designed to inhibit an identified metabolic pathway.
